R&D Systems™ Recombinant Human LAG-3 Fc Chimera Avi-tag Protein

Catalog No.	Quantity
AVI2319050	50 μg

Catalog No. AVI2319050 Supplier R&D Systems™ Supplier No. AVI2319050

Description

Biotinylated

Measured by its binding ability in a functional ELISA. When Recombinant Human Hepassocin/FGL1 His-tag (Catalog # 10285-HE ) is immobilized at 1 μg/mL (100 μL/well), the concentration of Recombinant Human LAG-3 Fc Chimera Avi-tag that produces 50% of the optimal binding response is 0.1-0.6 μg/mL.

Specifications

• Accession Number: P18627.5
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Gene ID (Entrez): 3902
• Molecular Weight (g/mol): M.W. (Observed): 81-92 kDa, under reducing conditions; M.W. (theoretical): 75 kDa
• Quantity: 50 μg
• Source: Chinese Hamster Ovary cell line, CHO-derived human LAG-3 protein Human LAG-3 (Leu23-Leu450) (N-terminus) Accession # P18627.5 IEGRMD Human IgG1 (Pro100-Lys330) Avi-tag (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Conjugate: Biotin
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: LAG-3